期刊文献+

肥胖高血压患者不同糖耐量情况下血脂及超敏C反应蛋白的变化 被引量:2

The Change of Lipids and High Sensitivity C-Reactive Protein in Different State of Glucose Tolerance in Obese Hypertensive Patients
下载PDF
导出
摘要 目的探讨肥胖高血压患者在不同糖耐量情况下血脂及超敏C反应蛋白(hs-CRP)的变化。方法选择2008年6—12月在我院住院的肥胖高血压患者65例,以糖耐量分组分为肥胖高血压糖耐量正常组(NGT)42例和糖耐量异常组(IGT)23例。比较两组患者胆固醇(TC)、三酰甘油(TG)、高密度脂蛋白(HDL)、低密度脂蛋白(LDL)及hs-CRP的变化。结果 IGT组hs-CRP水平显著高于NGT组,差异有统计学意义(P<0.05);两组患者TC、TG、HDL、LDL比较,差异均无统计学意义(P>0.05)。结论肥胖高血压患者合并IGT时,其潜在心血管疾病风险显著升高,需进行综合干预,降低心血管疾病的发病率和死亡率。 Objective To observe the changes of lipids and high sensitivity C - reactive protein ( hs - CRP) in different state of glucose tolerance in obese hypertensive patients. Methods In June 2008 to December 2008 in our hospital 65 cases of obese hypertensive patients with impaired glucose tolerance, divided into obese hypertensive subjects with normal glucose tolerance group (NGT) in 42 cases and abnormal glucose tolerance group (IGT) in 23 cases. Comparison of two groups of patients with cholesterol (TC), three triglycerides (TG), high density lipoprotein (HDL), low density lipoprotein (LDL) and - CRP changes. Results IGT level of hs - CRP group was higher than that in NGT group, the difference was statistically significant ( P 〈0. 05 ); in two patients with TC, TG, HDL, LDL comparison, there were no significant differences between them ( P 〉 0. 05 ). Conclusion Obesity hypertension patients complicated with IGT, the potential risk of cardiovascular disease increased significantly, need for comprehensive intervention, reduce the morbidity and mortality of cardiovascular disease.
作者 杨盼 牟建军
出处 《实用心脑肺血管病杂志》 2013年第2期32-33,共2页 Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease
关键词 肥胖症 高血压 血脂 C反应蛋白 Obesity Hypertension Lipids C-reactive protein
  • 相关文献

参考文献8

  • 1Samuel K, Lora E, Burke RN, et al. Clinical implications of obesity with specific focus on cardiovascular disease a statement for professionals from the American Heart Association Council on Nutrition, physical ac- tivity, and metabolism [J]. Circulation, 2004, 110: 2952-2967.
  • 2Hashimoto H, Kitagawa K. C - reactive protein is an independent pre- dictor of the rate of increase in early carotid atherosclerosis [J]. Circu- lation, 2001, 104: 63.
  • 3Ridker PM, Hennekens CH, Buring JE, et al. C - reactive protein and other markers of inflammation in the prediction of cardiovascular dis- ease in women [J]. N EnglJ Med, 2000, 342: 836-843.
  • 4Ridker PM, Cushman M, Stampfer MJ, et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men [J]. N Engl J Med, 1997, 336:973 -979.
  • 5夏娟,喻明.糖耐量受损:心血管疾病的重要危险因子[J].中国组织工程研究与临床康复,2007,11(51):10344-10348. 被引量:6
  • 6Pradhan AD, Ridker PM. Do atheroseleresis and type 2 diabetes share a common inflammation basis? [J]. Eur Heart J, 2002, 23:831 - 834.
  • 7Barzilay JI, Abraham L, Heckbert SR, et al. The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study [J]. Diabetes, 2001, 50 (10) : 2384 -2389.
  • 8Ford ES. Body mass index, diabetes, and C - reactive protein among U. S. adults [J]. DiabetesCaro, 1999, 22 (12): 1971-1977.

二级参考文献8

共引文献5

同被引文献25

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部